| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/09/2008 | EP1940471A1 IMPLANTABLE BIOCOMPATIBLE IMMtTNOISOLATORY VEHICLE FOR DELIVERY OF GDNF |
| 07/09/2008 | EP1940452A2 Cgrp peptide antagonists and conjugates |
| 07/09/2008 | EP1940450A2 Method of modulation |
| 07/09/2008 | EP1940447A1 Treatment of neurodegenerative disorders |
| 07/09/2008 | EP1940412A2 Novel opioid antagonists |
| 07/09/2008 | EP1940407A2 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators |
| 07/09/2008 | EP1940403A2 Ppar-gamma agonists for improvement of cognitive function in apoe4 negative patients |
| 07/09/2008 | EP1940398A1 Use of pramipexol for treating moderate to severe restless legs syndrome (rls) |
| 07/09/2008 | EP1940389A2 Modulation of neurogenesis by pde inhibition |
| 07/09/2008 | EP1940382A2 Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders |
| 07/09/2008 | EP1940376A2 Use of neboglamine in the treatment of toxicodependency |
| 07/09/2008 | EP1940373A2 Inositol derivatives and their uses in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, desposition, accumulation or persistence |
| 07/09/2008 | EP1794143B1 Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents |
| 07/09/2008 | EP1572167B1 Transdermal buprenorphine dosage regimen for analgesia |
| 07/09/2008 | EP1560823B1 4-substituted 1-aminocyclohexane derivatives for utilization as orl1-receptor and mu-opiate receptor ligands |
| 07/09/2008 | EP1534289B1 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 07/09/2008 | EP1465863B1 Potassium channel modulators |
| 07/09/2008 | EP1455756B1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 07/09/2008 | EP1448211B1 A composition for lowering the concentration of intestinal pathogenic peptides |
| 07/09/2008 | EP1399424B1 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide |
| 07/09/2008 | EP1392348B1 Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists |
| 07/09/2008 | EP1390367B1 DIHYDROIMIDAZO 5,1-A -$G(b)-CARBOLINE DERIVATIVES, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINE |
| 07/09/2008 | EP1379496B1 Sulphones which modulate the action of gamma secretase |
| 07/09/2008 | EP1338604B9 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres |
| 07/09/2008 | EP1332133B1 Metabotropic glutamate receptor antagonists |
| 07/09/2008 | EP1303490B1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 07/09/2008 | EP1303304B1 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 07/09/2008 | EP1276729B1 New neurokinin antagonists for use as medicaments |
| 07/09/2008 | EP1234041B1 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 07/09/2008 | EP1219624B1 Remedies for neuropathic pain and model animals of neuropathic pain |
| 07/09/2008 | EP1156820B1 Use of vascular endothelial growth factor-2 (vegf-2) |
| 07/09/2008 | EP1058680B1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 07/09/2008 | EP1043023B1 Viscous compositions containing carbon dioxide |
| 07/09/2008 | EP0970121B1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
| 07/09/2008 | EP0783577B1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 07/09/2008 | EP0734260B2 Paroxetine tablets and process to prepare them |
| 07/09/2008 | CN101218240A Process for preparing bicyclic compounds |
| 07/09/2008 | CN101218234A Phenyl-3-{(3-(1H-pyrrol-2-yl)-[1,2,4]oxadiazol-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 07/09/2008 | CN101218232A Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 07/09/2008 | CN101218231A Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 07/09/2008 | CN101218223A Benzodioxane and benzodioxolane derivatives and uses thereof |
| 07/09/2008 | CN101217959A Eslicarbazepine acetate and methods of use |
| 07/09/2008 | CN101217949A 治疗睡眠-清醒病症 Treatment of sleep - wake disorders |
| 07/09/2008 | CN101217936A Pharmaceutical formulation of apomorphine for buccal administration |
| 07/09/2008 | CN101215283A Secalonic acid A compound and its preparing method and application in preparing neuron cell protection medicament |
| 07/09/2008 | CN101215253A Crystalline forms of atorvastatin |
| 07/09/2008 | CN101214363A Liquid for sobering up and preparation thereof |
| 07/09/2008 | CN101214351A Medicament for treating Tourette syndrome |
| 07/09/2008 | CN101214329A Medicament for expelling wind and relieving pain and preparation thereof |
| 07/09/2008 | CN101214325A Method for preparing compound í«chenxiangweií»medicine and new use thereof |
| 07/09/2008 | CN101214312A Soft capsule for treating neurasthenia and preparation technique thereof |
| 07/09/2008 | CN101214310A Externally-applied Chinese medicine liniment for resisting cancer and relieving pain |
| 07/09/2008 | CN101214302A Pharmaceutical compositions for treating melancholia associated with functional dyspepsia and preparation |
| 07/09/2008 | CN101214301A Qingkailing freeze-drying preparations and preparation thereof |
| 07/09/2008 | CN101214281A Method for producing cistanche salsa extract |
| 07/09/2008 | CN101214270A Acanthopanax senticosus effective fraction extract, preparation and application thereof |
| 07/09/2008 | CN101214259A Pilose antler basic fibroblast growth factor (DEER FGF) extraction and preparation thereof |
| 07/09/2008 | CN101214257A Medicinal composition for treating diabetes chronic complication and preparation method thereof |
| 07/09/2008 | CN101214253A Application of anemarrhenasaponin B-II in preparing antidepressant product |
| 07/09/2008 | CN101214250A Use of hederagenin and its derivatives in preparing antidepressant product |
| 07/09/2008 | CN101214248A Triazolo[4,5-d] pyrimidine derivatives and their application as purinergic receptor antagonists |
| 07/09/2008 | CN101214237A Pharmaceutical use of dandelion xylogen acid for inhibiting acetylcholine esterase |
| 07/09/2008 | CN101214054A Health food with promoting lead-expelling function and auxiliary improving memory function |
| 07/09/2008 | CN101214029A Processing and selling novel technique for dinner and secondary dinner dietotherapeutic adding food jujube product |
| 07/09/2008 | CN100400540C Isoxazoline derivatives as anti-depressants |
| 07/09/2008 | CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 07/09/2008 | CN100400518C Phthalazinone derivatives |
| 07/09/2008 | CN100400513C Phenylalanine enamide derivatives |
| 07/09/2008 | CN100400509C Pyrrolidone derivatives as MAOB inhibitors |
| 07/09/2008 | CN100400504C Amide derivatives as inhibitors of the enzymatic activity of renin |
| 07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
| 07/09/2008 | CN100400100C Methods for preventing or attenuating patthoangiogenic conditions |
| 07/09/2008 | CN100400089C Sobering-up tea |
| 07/09/2008 | CN100400064C Glucoside compound preparation and its preparing process |
| 07/09/2008 | CN100400051C Medicinal composition, and its preparing method and use |
| 07/09/2008 | CN100400047C Medicine powder for injection for treating cardiac and cerebral vascular diseases and its preparing method and application |
| 07/09/2008 | CN100400043C Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances |
| 07/09/2008 | CN100400042C Methods for making sustained release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 07/09/2008 | CN100400040C Tripeptidyl peptidase inhibitors |
| 07/08/2008 | US7396910 Transient receptor potential channel TRPV3 and its use |
| 07/08/2008 | US7396859 Perturbed membrane-binding compounds |
| 07/08/2008 | US7396848 oxazole derivatives to treat diabetic neuropathy and/or other kinds of peripheral neuropathy; 4-(4-chlorophenyl)-5-[3-(2-methoxyphenoxy)propyl]-2-(2-methyl-1-imidazolyl)oxazole |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396836 Pyrimidine compound and medicinal composition thereof |
| 07/08/2008 | US7396834 e.g., 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]benzamide; opioid delta rreceptor agonist; analgesic, hypotensive agent; pain, anxiety and functional gastrointestinal disorders, immunomodulatory activities |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/08/2008 | US7396828 PI-3 kinase inhibitor prodrugs |
| 07/08/2008 | US7396826 prophylaxis/therapy of diabetes, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative and neuropathic diseases, neuropathic pain, polyneuropathy using e.g. Octadeca-6,9,12-trienoic acid 5' -(2,4-dioxo-3,4-dihydro-2H-pyrimidine-1-yl)-3',4 dihydroxy-tetrahydrofuran-2'-yl methyl ester |
| 07/08/2008 | US7396824 2-O sulfatase nucleic acid compositions |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | CA2505506C Compounds which can be used to diagnose and monitor diseases associated with the formation of amyloid protein fibrils |
| 07/08/2008 | CA2445620C Tetracyclic compounds as pde5-inhibitors |
| 07/08/2008 | CA2438596C Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2420177C Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 07/08/2008 | CA2372377C A novel inhibitor of beta amyloid cleavage enzyme |
| 07/08/2008 | CA2360754C Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors |
| 07/08/2008 | CA2333154C Microemulsion preconcentrates containing a piperidine substance p antagonist |
| 07/08/2008 | CA2306830C Use of adamantane amines or structurally similar compounds for combating borna disease virus and for the prevention and treatment of affective diseases and other disorders associated with bdv infections in humans and animals |
| 07/03/2008 | WO2008080170A1 Mixed drug aerosol compositiions |